MM6A Stock Overview
Offers home and alternate site infusion services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Option Care Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$29.60 |
| 52 Week High | US$32.00 |
| 52 Week Low | US$20.40 |
| Beta | 1.33 |
| 1 Month Change | -0.67% |
| 3 Month Change | 33.33% |
| 1 Year Change | 2.07% |
| 3 Year Change | 24.37% |
| 5 Year Change | 373.60% |
| Change since IPO | 207.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| MM6A | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -4.5% | -0.7% | -0.5% |
| 1Y | 2.1% | 42.9% | 15.5% |
Return vs Industry: MM6A underperformed the German Healthcare industry which returned 42.9% over the past year.
Return vs Market: MM6A underperformed the German Market which returned 15.5% over the past year.
Price Volatility
| MM6A volatility | |
|---|---|
| MM6A Average Weekly Movement | 5.8% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in DE Market | 12.0% |
| 10% least volatile stocks in DE Market | 2.8% |
Stable Share Price: MM6A has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: MM6A's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 7,052 | John Rademacher | www.optioncarehealth.com |
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer’s disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services.
Option Care Health, Inc. Fundamentals Summary
| MM6A fundamental statistics | |
|---|---|
| Market cap | €4.96b |
| Earnings (TTM) | €194.64m |
| Revenue (TTM) | €4.59b |
25.5x
P/E Ratio1.1x
P/S RatioIs MM6A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MM6A income statement (TTM) | |
|---|---|
| Revenue | US$5.00b |
| Cost of Revenue | US$3.99b |
| Gross Profit | US$1.01b |
| Other Expenses | US$801.17m |
| Earnings | US$211.82m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.28 |
| Gross Margin | 20.27% |
| Net Profit Margin | 4.24% |
| Debt/Equity Ratio | 79.1% |
How did MM6A perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/16 05:29 |
| End of Day Share Price | 2025/03/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Option Care Health, Inc. is covered by 11 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| Joanna Sylvia Gajuk | BofA Global Research |
| Richard Close | Canaccord Genuity |